Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

redx

Former Merck R&D expert joins RedX Pharma board

January 4, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing RedX Pharma

Dr Bernhard Kirschbaum, 57, has been added as a non-executive director at RedX Pharma with immediate effect. Kirschbaum is a …
Appointment
Ebola virus

WHO to review MSD’s Ebola vaccine for emergency use

December 24, 2015 Manufacturing and Production, Research and Development Ebola vaccine, Ebola virus, MSD, WHO, Zebov

The World Health Organisation (WHO) has accepted MSD’s application for the company’s investigational Ebola vaccine, V920 (Zebov), to be reviewed …
News
2016

Seven pharma trends for 2016

December 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing M&A, MA, biosimilars, collaborations, digital pharma, emerging markets, patient centricity, pharma, pricing

What will be the key industry trends in 2016?Pricing pressures
Feature
Celgene logo

Celgene settles Revlimid patent dispute

December 23, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Celgene, India, Natco, Revlimid, lenalidomide, patents

Celgene has settled its litigation with Natco Pharma, over the patents for Revlimid, opening the door to increased generic competition …
News
melanoma cell

100 year old chemical could be the future of cancer treatment

December 23, 2015 Research and Development Cancer, PV-10, Peter Culpepper, Provectus, Rose Bengal, oncology

Peter Culpepper, chief operating officer at Provectus Biopharmaceuticals, explains the secrets of Rose Bengal, which has impressed in clinical trials …
Feature
Nucala

Researchers question price of GSK’s Nucala

December 23, 2015 Research and Development GSK, HEOR, ICER, Nucala, asthma, cost-effective, health economics, health economics outcomes research

GSK is charging up to four times more for its recently approved asthma drug Nucala than is justified by cost-effectiveness …
News
Bavarian Nordic logo

Janssen and Bavarian Nordic to collaborate on HPV vaccine

December 23, 2015 Research and Development Bavarian Nordic, HPV, Janssen, Vaccine, human papillomavirus, prime boost

Janssen has announced a new collaboration and license agreement with Bavarian Nordic to develop a vaccine for chronic Human Papillomavirus …
News
CT scan

Merck and Pfizer kick off Phase III avelumab cancer trials

December 23, 2015 Research and Development Merck, Pfizer, avelumab, ovarian cancer

Merck and Pfizer have announced the opening of trial sites for an international Phase III study of avelumab in patients …
News
Actelion building

Actelion ready to launch Uptravi after FDA approval

December 22, 2015 Research and Development, Sales and Marketing Actelion, FDA, Jean-Paul Clozel, Uptravi, pulmonary arterial hypertension, selexipag

Actelion says it is ready to launch Uptravi, its drug for pulmonary arterial hypertension in the US in January, after …
News
Flemming Ornskov

Shire moves to seal Baxalta deal with improved offer

December 22, 2015 Research and Development, Sales and Marketing Baxalta, Flemming Ornskov, Shire

Shire is set to sweeten its $30 billion bid for Baxalta by offering 40% of the total, or $12 billion, …
News

Former Cubist chief executive Michael Bonney to chair board at Alnylam

December 22, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Alnylam, David Pyott, michael bonney

Michael Bonney, current board member and former chief executive of Cubist Pharmaceuticals, has been appointed as chairman of Alnylam Pharmaceuticals …
Appointment
Keytruda image

MSD’s Keytruda impresses in lung cancer chemotherapy trial

December 21, 2015 Manufacturing and Production, Research and Development MSD, PD-L1, docetaxel, keytruda, lung cancer, non small cell lung cancer, non-small cell lung cancer, pd-1, pembrolizumab

MSD’s Keytruda significantly improved overall survival (OS) compared to chemotherapy in people with lung cancer and PD-L1 expression, a trial …
News

Novartis completes purchase of rights to GSK drug for up to $1bn

December 21, 2015 Manufacturing and Production, Research and Development, Sales and Marketing

Novartis has completed the acquisition of all outstanding rights to Arzerra from GSK for up to $1.034 billion. The deal, …
News
ceo_arnaud_lallouette

Servier UK appoints new chief executive

December 18, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Arnaud Lallouette, Mike Sumpter, Servier

Dr Arnaud Lallouette has been appointed chief executive of Servier Laboratories, the UK subsidiary of the French-based pharma firm, after …
Appointment
tim-walbert

Horizon chief exec Walbert to head up US biotech trade body

December 18, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Illinois Biotechnology Industry Organisation, Timothy Walbert, iBio, illinois

Timothy Walbert, the chairman, president and chief executive of Horizon Pharma, has been elected as chairman of the board of …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025